Because of its role as a central modulator of extracellular and intracellular signaling of mediators and growth factors associated with negative tumor behaviors, the mTOR pathway has become an attractive target for a class of targeted anti-tumor agents. The gene discussed is MTOR; the disease is neoplasm.